November 29, 2012

In 2011 and 2012, the steady surge of blockbuster pharmaceuticals falling off the patent cliff became a stampede. An astonishing number of big-selling drugs that had established and sustained branded drug makers’ profits for years fell victim to the expiration of their patent lives and market exclusivity, roiling the pharmaceutical marketplace and redefining the pricing model for many of the most widely prescribed classes of medicines.


November 29, 2012

Generic Pharmaceutical Association president and CEO Ralph Neas called it “the most important pharmaceutical legislation since the 1984 Hatch-Waxman Act.” John Castellani, president and CEO of the Pharmaceutical Research and Manufacturers of America, said the law served “the best interests of America’s patients.”


November 28, 2012

Physicians Interactive and McKesson Patient Relationship Solutions on Tuesday announced a joint collaboration to deliver eCoupon, one of the industry’s first automated pharmaceutical voucher and coupon distribution solution for clinicians who use electronic health records and ePrescribing software.

November 21, 2012

During Fred's third-quarter earnings call, the company told analysts it was testing a new, smaller format drug-dollar store concept and that its partnership with Diplomat was creating new clinical capabilities for the chain, which still sees pharmacy as a major growth opportunity.

The more Memphis-area patients continue singing those Delta blues, the more they're going to be scuffling through Fred's doors in their blue suede shoes. Effectively serving that economically-challenged patient is just one reason why Fred's third-quarter call this week should resonate across the industry. Because Fred's is in pursuit of two trends that are critical to its future — a specialty pharmacy solution that gains Fred's entree into the only growth-game in pharmacy, and an answer to its big-box competitors with a small-footprint, dollar-store/pharmacy hybrid.

November 15, 2012

Spurred by health reform and other factors, a "golden era" could be approaching for drug companies as they reinvent themselves, according to a new report by PwC.

November 5, 2012

Rx Response, an initiative of America’s bio-pharmaceutical supply system to help ensure the continued flow of medicine to patients in a severe public health emergency, has continued its close coordination with federal, state and local government agencies to address impacts from Hurricane Sandy on the bio-pharmaceutical supply system, the organization announced Friday.

October 24, 2012

Several cities across the country will play host to a new program from one drug maker to recycle respiratory inhalers.

October 23, 2012

Boots No7 is celebrating its 77th anniversary with a reinvigorated brand image and new products for the U.S. market.

October 19, 2012

Healthcare product sales through the nation’s primary healthcare distributors hit a record high of $294 billion in 2011, according to the 2012-2013 HDMA Factbook released Friday.

October 16, 2012

H.D. Smith, one of the largest pharmaceutical wholesalers in the United States, announced plans to acquire Valley Wholesale Drug in a merger agreement transaction.

October 16, 2012

Emerging multidisciplinary healthcare models, such as accountable care organizations and patient-centered medical homes, promise to elevate quality and lower costs by harnessing the power of provider, payer and patient collaboration. Often overlooked in the coordinated care equation, however, is the integral role pharmacists can play in delivering efficient and effective care.

October 9, 2012

ValueCentric and the American Pharmacy Alliance have entered a collaboration, which will connect pharmaceutical manufacturers with independent pharmacy data.

October 4, 2012

The Keystone Folding Box Co. has launched a pharmaceutical compliance packaging system that it said was environmentally sustainable, easy to use for elderly people and resistant to tampering by children.

September 28, 2012

Keynote speeches by pharmaceutical industry and regulatory leaders got top billing as more than 140 government, healthcare industry, law enforcement and patient advocacy officials gathered to find ways to combat the spread of counterfeit medicines.

September 25, 2012

Patients diagnosed with serious disease have enough on their minds. So Walgreens is doing all it can to make it easier for them to obtain, administer and pay for their specialty and infused medicines, said Mike Ellis, VP specialty pharmacy and infusion.


September 25, 2012

Walgreens is fundamentally changing the way it does business with both its upstream pharmaceutical suppliers and its downstream customers in the managed care world.

September 25, 2012

As the largest single purchaser of prescription drugs in the world, with a global pharmaceutical wholesale operation to match, in-house manufacturing capabilities in over-the-counter health and wellness and generic drugs, Walgreens-Alliance Boots will have a whole lot more influence on the pharmacy side of its business.


September 24, 2012

McKesson on Monday named Mark Walchirk president of its U.S. pharmaceutical division, effective immediately.

September 21, 2012

The pharmaceuticals business will begin picking up in 2014, AmerisourceBergen president and CEO Steve Collis said at the wholesaler's ThinkLive Manufacturer's Summit.

September 20, 2012

Alliance Boots, under the terms of a strategic alliance agreement signed earlier this week, announced that it will acquire a 12% stake in Nanjing Pharmaceutical for a total consideration of approximately $90.7 million.

September 18, 2012

A trillion of anything is difficult to wrap one’s head around, whether it’s the number of grains of sand on a beach or stars in the sky. It’s so much easier for the human mind to look at such a quantity as the sum of its parts rather than on the basis of its individual components.


September 18, 2012

2012 is turning out to be a pretty important year for generic drugs, important enough that some of the things happening over the past several months have begged comparison to 1984, probably the biggest milestone year for the industry.


September 18, 2012

For branded drug makers, the pharmaceutical patent cliff has never loomed higher or steeper. The exposure of so many of the world’s biggest-selling medicines to generic competition for the first time is redefining the pricing model for many of the most widely prescribed classes of pharmaceuticals.

September 10, 2012

H. D. Smith, one of the nation’s largest pharmaceutical wholesalers, on Monday named Timothy Booth to corporate VP and head of its home healthcare division.